SCHEMBL6858608

SCHEMBL6858608

CCCC(CC)OC(=O)c1cc(C(=O)OC(CC)CCC)cc(S(=O)(=O)[O-])c1.CCCC(CC)OC(=O)c1cc(C(=O)OC(CC)CCC)cc(S(=O)(=O)[O-])c1.[Ba+2]

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.62
PRKCD Q05655 2/20 0.62
SERPINE1 P05121 1/20 0.34
NR1I2 O75469 1/20 0.33
CA1 P00915 5/20 0.32
CA2 P00918 5/20 0.32
LMNA P02545 2/20 0.32
CA7 P43166 2/20 0.32
CA14 Q9ULX7 2/20 0.32
HSD17B10 Q99714 1/20 0.31
CA12 O43570 1/20 0.31
CA9 Q16790 1/20 0.31
PTPN1 P18031 2/20 0.31
PTPN2 P17706 1/20 0.31
PTPN11 Q06124 1/20 0.31
ESR1 P03372 1/20 0.31
PDE4A P27815 1/20 0.30
PDE4B Q07343 1/20 0.30
PDE4C Q08493 1/20 0.30
PDE4D Q08499 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6293178 0.97 PRKCA (0.62) PRKCAPRKCDSERPINE1NR1I2CA1
SCHEMBL6856593 0.91 PRKCA (0.49) PRKCAPRKCDSERPINE1CA1CA2
SCHEMBL6855985 0.91 PRKCA (0.59) PRKCAPRKCDNR1I2ESR1
SCHEMBL6292960 0.88 PRKCA (0.49) PRKCAPRKCDSERPINE1CA1CA2
SCHEMBL6291913 0.88 PRKCA (0.59) PRKCAPRKCDNR1I2ESR1
SCHEMBL6856281 0.84 PRKCA (0.43) PRKCAPRKCDNR1I2CA1CA2
SCHEMBL6858610 0.84 PRKCA (0.63) PRKCAPRKCDSERPINE1CA1CA2
SCHEMBL6293179 0.84 PRKCA (0.63) PRKCAPRKCDSERPINE1CA1CA2
SCHEMBL6291923 0.82 PRKCA (0.43) PRKCAPRKCDNR1I2CA1CA2
SCHEMBL6855748 0.80 PRKCA (0.45) PRKCAPRKCDNR1I2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6830859-B2 Electrostatic latent images; containing barium salt of sulfoisophthalic acid RICOH COMPANY, LTD. (JP) 2004-12-14 US disclosed
US-20030077534-A1 Charge control agent and toner using same RICOH COMPANY, LTD. (JP) 2003-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030077534-A1 Charge control agent and toner using same BET1, SMARCA5, SMARCA1 PRKCA 4466/4885PRKCD 4692/4885SERPINE1 1081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.